Homeβ€ΊSearchβ€ΊEuropean Neuropsychopharmacology

European Neuropsychopharmacology

Elsevier B.V. Β· Netherlands Β· Est. 1990

ISSN1873-7862
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJR
96
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (3 more)+18
Total96
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
Publication speed: not measurable
publisher doesn’t disclose per-article submission dates β€” we never estimate
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
2.334
H-Indexi
156
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
1.34
Total Worksi
35,290
Total Citationsi
186,414
2yr Mean Citednessi
1.00
Open Impact Factor alternative
Retractions
1
Source: Retraction Watch

Aims & Scope

Subject areas: Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry; Biological Psychiatry; Neurology; Neurology (clinical); Pharmacology; Pharmacology (medical); Psychiatry and Mental Health.

General Information

Country / RegionNetherlands
Primary LanguageEnglish
1st Year Published1990
Frequency6 No. A Year, 1999-
StatusActive (last: 2026)
Total Publications35,290
Publisher OrgElsevier BV
Visit Journal Website

Submission Info

Peer Reviewβ€”
Review Timeβ€”
Acceptance Rateβ€”
OA Licenseβ€”
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes

Think.Check.Submit Compliance

6/12 Β· 50%
βœ…
Do you know the journal / publisher?
Elsevier B.V.
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
1873-7862
βœ…
Indexed in a trusted database?
WoS, Scopus
❌
Peer review process documented?
N/A
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
❌
Plagiarism detection in place?
N/A
❌
Listed in DOAJ (verified OA)?
N/A
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
3.6k
5.3k
2019
911
5.2k
2020
1.6k
4.7k
2021
711
2.2k
2022
657
2.2k
2023
687
1.3k
2024
620
340
2025
94
31
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Biological PsychiatryQ1
NeurologyQ1
Neurology (clinical)Q1
PharmacologyQ1
Pharmacology (medical)Q1
Psychiatry and Mental HealthQ1

Subject Classification

Web of Science Categories

Clinical NeurologyNeurosciencesPharmacology & PharmacyPsychiatry

Scopus Categories

PharmacologyPharmacology (medical)Neurology (clinical)Biological PsychiatryPsychiatry and Mental HealthNeurology

Research Topics (OpenAlex)

Schizophrenia research and treatmentTreatment of Major DepressionBipolar Disorder and TreatmentTryptophan and brain disordersNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology ResearchStress Responses and CortisolAttention Deficit Hyperactivity DisorderFunctional Brain Connectivity StudiesReceptor Mechanisms and Signaling

Frequently asked questions about European Neuropsychopharmacology

Is European Neuropsychopharmacology a predatory journal?

PubScope has no integrity flags on record for European Neuropsychopharmacology: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of European Neuropsychopharmacology?

European Neuropsychopharmacology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.00.

Is European Neuropsychopharmacology indexed in Scopus and Web of Science?

European Neuropsychopharmacology is indexed in Web of Science, Scopus.

What is the aims and scope of European Neuropsychopharmacology?

Subject areas: Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry; Biological Psychiatry; Neurology; Neurology (clinical); Pharmacology; Pharmacology (medical); Psychiatry and Mental Health.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref